Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Hubbard

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 14, 1999
Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domainK Nelms, T J O'Neill, S Li, et al.
Science (New York, N.Y.)|December 20, 1991
Identification and characterization of zinc binding sites in protein kinase CS R Hubbard, W R Bishop, P Kirschmeier, et al.
Nature Structural Biology|January 3, 2001
Mechanism-based design of a protein kinase inhibitorK Parang, J H Till, A J Ablooglu, et al.
The Journal of Biological Chemistry|January 2, 2001
Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanismJ H Till, A J Ablooglu, M Frankel, et al.
Science (New York, N.Y.)|May 9, 1997
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitorsM Mohammadi, G McMahon, L Sun, et al.
The Journal of Biological Chemistry|June 28, 2000
Probing the catalytic mechanism of the insulin receptor kinase with a tetrafluorotyrosine-containing peptide substrateA J Ablooglu, J H Till, K Kim, et al.
Nature|February 9, 1995
Catalytic specificity of protein-tyrosine kinases is critical for selective signallingZ Songyang, K L Carraway, M J Eck, et al.
The EMBO Journal|October 17, 1998
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domainM Mohammadi, S Froum, J M Hamby, et al.
Pediatrics|January 31, 1998
Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical courseE Holinski-Feder, M Weiss, O Brandau, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|December 14, 1999
Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domainK Nelms, T J O'Neill, S Li, et al.
Science (New York, N.Y.)|December 20, 1991
Identification and characterization of zinc binding sites in protein kinase CS R Hubbard, W R Bishop, P Kirschmeier, et al.
Nature Structural Biology|January 3, 2001
Mechanism-based design of a protein kinase inhibitorK Parang, J H Till, A J Ablooglu, et al.
The Journal of Biological Chemistry|January 2, 2001
Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanismJ H Till, A J Ablooglu, M Frankel, et al.
Science (New York, N.Y.)|May 9, 1997
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitorsM Mohammadi, G McMahon, L Sun, et al.
The Journal of Biological Chemistry|June 28, 2000
Probing the catalytic mechanism of the insulin receptor kinase with a tetrafluorotyrosine-containing peptide substrateA J Ablooglu, J H Till, K Kim, et al.
Nature|February 9, 1995
Catalytic specificity of protein-tyrosine kinases is critical for selective signallingZ Songyang, K L Carraway, M J Eck, et al.
The EMBO Journal|October 17, 1998
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domainM Mohammadi, S Froum, J M Hamby, et al.
Pediatrics|January 31, 1998
Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical courseE Holinski-Feder, M Weiss, O Brandau, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Pageof 3